Maligna hudmelanom svår klinisk diagnos: Den primära handläggningen ofta bristfällig

Lakartidningen

Volumn , Issue 28-29, 1997, Pages 2539-2543

  Wallberg, Birgitta ^b   Hansson, Johan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BIOPSY; CASE REPORT; CLINICAL COMPETENCE; DIAGNOSTIC ERROR; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SKIN TUMOR; STANDARD;

ADULT; AGED; BIOPSY; CLINICAL COMPETENCE; DIAGNOSTIC ERRORS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SKIN NEOPLASMS;

EID: 0031560985     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. The Swedish Cancer Registry. Cancer incidence in Sweden 1993. Stockholm. National Board of Health and Welfare, Center for Epidemiology, 1996.
2. Balch C, Reintgen DS, Kirkwood JM, Houghton A, Peters L, Kian Ang K. Cutaneous melanoma. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer. Principles and practice of oncology. 5 ed. Philadelphia: JB Lippincott-Raven, 1997: 1947-94.
3. Beitner H, Jacobsson S, Jönsson PE, Lagerlöf B. Användandet av stansbiopsier får ej missbrukas! Läkartidningen 1991; 88: 3262.
4. Austin JR, Byers RM, Brown WD, Wolf P. Influence of biopsy on the prognosis of cutaneous melanoma of the head and neck. Head Neck 1996; 18: 107-17
5. Thörn M, Adami HO, Ringborg U, Bergström R, Krusemo UB. The association between anatomic site and survival in malignant melanoma. An analysis of 12,353 cases from the Swedish Cancer Registry. Eur J Cancer Clin Oncol 1989; 25: 483-91.
6. Rampen FHJ, van Houten WA, Hop WCJ. Incisional procedures and prognosis in malignant melanoma. Clin Exp Dermatol 1980; 5: 313-20.
7. Rampen FHJ, van der Esch EP. Biopsy and survival of malignant melanoma. J Am Acad Dermatol 1985; 12: 385-8.
8. Penneys NS. Excision of melanoma after initial biopsy. An immunohistochemical study. J Am Acad Dermatol 1985; 13: 995-8.
9. Lederman JS, Sober AJ. Does biopsy type influence survival in clinical stage I cutaneous melanoma? J Am Acad Dermatol 1985; 13: 983-7.
10. Sondergaard K, Schou G. Therapeutic and clinico-pathological factors in the survival of 1 469 patients with primary cutaneous malignant melanoma in clinical stage I. Virchows Arch A [Pathol Anat] 1985; 408: 249-58.
11. Lees VC, Briggs JC. Effect of initial biopsy procedure on prognosis in stage I invasive cutaneous malignant melanoma: review of 1 086 patients. Br J Surg 1991; 78: 1108-10.
12. Witheiler DD, Cockerell CJ. Sensitivity of diagnosis of malignant melanoma: A clinicopathologic study with a critical assessment of biopsy techniques. Exp Dermatol 1992; 1: 170-5.
13. Månsson-Brahme E, Carstensen J, Erhardt K, Lagerlöf B, Ringborg U, Rutqvist LE. Prognostic factors in thin cutaneous malignant melanoma. Cancer 1994; 73: 2324-32.
14. Epidemiologiskt centrum, Socialstyrelsen och Cancerfonden. Cancer i siffror. Stockholm. 1995, 48-9.
15. Seidal T, Söderberg M. Kutana maligna melanom. Läkartidningen 1993; 90: 2605-8.
16. Anderson W, Silvers D. Melanoma? It can't be melanoma! A subset of melanomas that defies clinical recognition. JAMA 1991; 266: 3463-5.
17. Rahbari H, Nabai H, Mehregan AH, Mehregan DA, Mehregan DR, Lipinsky J. Amela-notic lentigo maligna melanoma. Cancer 1996; 77: 2052-7.
18. Steiner A, Konrad K, Pehamberger H, Wolff K. Verrucous malignant melanoma. Arch Dermatol 1988; 124: 1534-7.
19. Menzies SW, Crotty KA, Ingvar C, McCarthy WH. An atlas of surface microscopy of pigmented skin lesions. Sydney: McGraw-Hill, 1996.
20. Månsson-Brahme E. Vilka diagnostiserar malignt melanom? Kartläggning av praxis. I: Konsensuskonferens 16-18 november 1994. Alt förebygga malignt melanom. Program och föredrag. Stockholm: Spri/MFR, 1994: 111.